Lyell Immunopharma, Inc. · NASDAQ:LYEL
Lee Gary K. sold 129 Lyell Immunopharma, Inc. shares (Form 4)
Traded Nov 10, 2026 · Filed Nov 12, 2026
On Nov 10, 2026, Lee Gary K. (Chief Scientific Officer) sold 129 Lyell Immunopharma, Inc. shares at US$15.93 for US$2,055, leaving 16,091 shares. Filed Nov 12, 2026 (Form 4).
- Sold
- 129 shares
- Price
- US$15.93
- Value
- US$2,055
- Holding after
- 16,091 shares
- Trading plan
- No
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Common Stock | Sale | 129 | US$15.93 | 16,091 | Direct |
Source
Download original · View original at SEC
Related
- Lyell Immunopharma, Inc.
- Lee Gary K.
- Lyell Immunopharma, Inc. shareholders
- Form 4 · Lee Gary K. · Aug 25, 2026
- Form 4 · Lee Gary K. · Aug 11, 2026
- Form 4 · Lee Gary K. · Jun 15, 2026
- Form 4 · Seely Lynn · Nov 12, 2026
- Form 4 · Hill Stephen J. · Nov 12, 2026
- Form 4 · Bulis Veronica Sanchez · Nov 12, 2026
- Schedule 13G/A · ARCH Venture Fund IX, L.P. · Nov 10, 2026
- Form 4 · ARCH Venture Partners IX, LLC · Nov 5, 2026